✦ LIBER ✦

P.3.a.015 Efficacy and safety of olanzapine long-acting injection for maintenance treatment of schizophrenia

✍ Scribed by H. Detke; D. McDonnell; J. Kane; D. Naber; G. Sethuraman; D. Lin

Book ID: 118595010
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 69 KB
Volume: 18
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(08)70568-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.3.a.015 Study of the efficacy and safe

P.3.a.015 Study of the efficacy and safety of risperidone long acting injection in elderly schizophrenia patients

✍ Y. Inoue; H. Suzuki; M. Ootomo; S. Takeda; Y. Kawaguchi; K. Gen 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 42 KB

P.3.c.006 Safety and efficacy of olanzap

P.3.c.006 Safety and efficacy of olanzapine long-acting injection for up to 6 years in patients with schizophrenia or schizoaffective disorder

✍ D.P. McDonnell; H.C. Detke; M. Choukour; J. Landry 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 77 KB

PMH3 Olanzapine Long-Acting Injection fo

PMH3 Olanzapine Long-Acting Injection for Schizophrenia: An Evaluation of Patient Functioning During 24 Weeks of Maintenance Therapy

✍ D. Novick; H. Anand; H. Ascher-Svanum; J. Haro; J. Bertsch; Z. Cui; H. Detke; D. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PMH42 COST-EFFECTIVENESS ANALYSIS OF OLA

PMH42 COST-EFFECTIVENESS ANALYSIS OF OLANZAPINE LONG-ACTING INJECTION COMPARED WITH RISPERIDONE LONG-ACTING INJECTION IN THE TREATMENT OF SCHIZOPHRENIA IN NORWAY

✍ SM Carroll; N Jemiai; B Suter; P O'Donohoe; U Skjoldborg; J Moller; OK Kleivenes 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

Comparison of metabolic changes in patie

Comparison of metabolic changes in patients with schizophrenia during randomized treatment with intramuscular olanzapine long-acting injection versus oral olanzapine

✍ David P. McDonnell; Ludmila A. Kryzhanovskaya; Fangyi Zhao; Holland C. Detke; Pe 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB 👁 1 views

Metabolic changes were examined in patients with schizophrenia during treatment with either oral olanzapine or olanzapine long‐acting injection (LAI). Data were collected from patients who had been stabilized on oral olanzapine (10, 15, or 20 mg/day) for ≥4 weeks and then randomized to either contin

P.3.c.017 Effectiveness and tolerability

P.3.c.017 Effectiveness and tolerability of olanzapine long-acting injection versus first-generation depot for schizophrenia: clinical outcomes

✍ V. Fricchione Parise; G. Balletta; L. Addeo; M.G. Foti 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 73 KB